Successful prevention of severe allergic transfusion reactions with omalizumab.

Transfusion
Sensen ShiYing Wang

Abstract

Allergic transfusion reactions (ATRs) are a common adverse reaction to transfusion therapy and can be potentially fatal. Washing blood products is the most effective strategy for preventing ATRs; however, washed products, especially platelets, are not available at many blood centers. A 29-year-old female patient with an advanced myelodysplastic/myeloproliferative neoplasm, unclassifiable, developed severe ATRs after four platelet transfusions in a week. She showed no response to premedication with histamines and steroids and still had severe ATRs with the next three platelet transfusions. A laboratory workup revealed that her IgA level was slightly decreased, while her haptoglobin level was normal. Anti-IgA testing was not available. The patient decided to undergo allogeneic peripheral blood stem cell (PBSC) transplantation. As the onset of symptoms ATR, which were similar to Type 1 hypersensitivity reactions mediated by IgE antibodies, occurred immediately after transfusion and omalizumab is a humanized monoclonal anti-IgE, we elected to offer off-label use of omalizumab before administering the conditioning regimen. Omalizumab was injected subcutaneously at a dose of 150 mg. Surprisingly, transfusion reactions fully resolved ...Continue Reading

References

May 8, 2007·The Journal of Allergy and Clinical Immunology·Melody C CarterDean D Metcalfe
May 26, 2007·Transfusion·Aaron A R TobianPaul M Ness
Dec 6, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Jeremy D JonesJohn M Fahrenholz
Sep 25, 2012·Transfusion·William J SavagePaul M Ness
Oct 16, 2012·Current Allergy and Asthma Reports·Jay A Lieberman, Mirna Chehade
Feb 19, 2014·Current Opinion in Allergy and Clinical Immunology·Carlos E Baena-Cagnani, R Maximiliano Gómez
Jul 1, 2017·Allergy·S Broesby-OlsenUNKNOWN Mastocytosis Centre Odense University Hospital (MastOUH)
Jul 28, 2017·Türk Pediatri Arşivi·Öner ÖzdemirBahri Elmas
Jan 10, 2018·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·J A Dantzer, R A Wood
Oct 1, 2019·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Maria C Sanchez-ValenzuelaAlexei Gonzalez-Estrada

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.